Lori Pierce, Helen Coley Nauts, and National Cancer Program milestones

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Women’s History Month

Lori J. Pierce, MD, FASTRO, FASCO began her term as the American Society of Clinical Oncology’s 57th president on June 1, 2020, making her ASCO’s first African American woman to hold this prestigious title. The desire to pursue a career in medicine took root when Dr. Pierce was a young child visiting family in segregated Ahoskie, North Carolina. She witnessed firsthand the impact the town’s lone African American family physician had on the community.

Helen Coley Nauts, the founder of the Cancer Research Institute (CRI), was a high school-educated housewife and mother who, from the time of her father’s death in 1936 until her own passing in 2001, would go on to fundamentally change the fields of cancer research and immunology. Her determination and perseverance in the face of constant resistance from the medical establishment of her day laid the foundation for cancer immunotherapy as it is known today.


Quote of the week

We are constantly aware that the [National Cancer Program] is unique for the federal government and for medicine. It has responsibility not only to conduct and foster cancer and related research, but to coordinate all cancer research done in the United States and to establish interrelationships in other countries as well.

Frank J. Rauscher, Jr.

Recent contributions


Primary Sources


This column features the latest posts to the Cancer History Project by our growing list of contributors.

The Cancer History Project is a free, web-based, collaborative resource intended to mark the 50th anniversary of the National Cancer Act and designed to continue in perpetuity. The objective is to assemble a robust collection of historical documents and make them freely available.

Access to the Cancer History Project is open to the public at CancerHistoryProject.com. You can also follow us on Twitter at @CancerHistProj.

Is your institution a contributor to the Cancer History Project? Eligible institutions include cancer centers, advocacy groups, professional societies, pharmaceutical companies, and key organizations in oncology.

To apply to become a contributor, please contact admin@cancerhistoryproject.com.

Table of Contents

YOU MAY BE INTERESTED IN

Shearwood McClelland III’s grandfather was a ditchdigger who dreamed that his six Black daughters would become doctors. McClelland’s mother did not disappoint—she became the first Black woman board-certified in maternal fetal medicine in the history of the United States.  Now, McClelland is the chief medical officer of Cancer Health Equity at the University of Oklahoma...

As oncology enters a new era of precision medicine, the Food and Drug Administration’s evolving biomarker strategy aims to ensure that life-saving therapies are tailored to individual patient needs, fostering safer and more effective treatments.  Historically, therapies were approved with broad indications based on overall efficacy, even when outcomes for biomarker-positive and -negative patients were...

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login